RNS60
Sponsors
Revalesio Corporation, Sabrina Paganoni, M.D., Mario Negri Institute for Pharmacological Research
Conditions
ALSAmyotrophic Lateral SclerosisAnterior Cruciate Ligament ReconstructionAsthmaHip Labral TearMyocardial InfarctStroke, IschemicSystemic Bioactivity of Nebulized RNS60
Phase 1
Safety Study of Nebulized RNS60 to Treat Asthma.
CompletedNCT01057498
Start: 2010-05-31End: 2011-01-31Updated: 2012-01-12
Safety and Tolerability of RNS60 Given by IV to Healthy Subjects
CompletedNCT01264783
Start: 2011-07-31End: 2011-09-30Updated: 2011-10-04
Study of Inhaled RNS60 in Combination With Budesonide to Treat Mild to Moderate Asthma
CompletedNCT01511302
Start: 2012-06-30End: 2013-05-31Updated: 2014-07-28
Systemic Bioactivity of Inhaled Nebulized RNS60
CompletedNCT02490865
Start: 2015-07-31End: 2015-08-31Updated: 2015-09-22
A Pilot Study of RNS60 in Amyotrophic Lateral Sclerosis (ALS)
CompletedNCT02525471
Start: 2015-10-31End: 2017-10-18Updated: 2021-05-28
Phase 2
Study of RNS60 on Pain and Function After Knee Anterior Cruciate Ligament Surgery
WithdrawnNCT01922427
Updated: 2015-04-10
Study of RNS60 on Pain and Function After Hip Labral Repair
WithdrawnNCT02005523
Updated: 2015-02-06
Effect of RNS60 on the Late Phase Asthmatic Response to Allergen Challenge
CompletedNCT02422121
Start: 2015-04-30End: 2015-11-30Updated: 2016-12-09
Pilot Study of RNS60 in Allergen-induced Bronchoconstriction
WithdrawnNCT02497222
Updated: 2016-10-04
Nebulized RNS60 for the Treatment of Amyotrophic Lateral Sclerosis
WithdrawnNCT02988297
Start: 2026-10-01End: 2028-11-01Updated: 2026-04-16
The Effect of RNS60 on ALS Biomarkers
CompletedNCT03456882
Start: 2017-05-30End: 2021-05-30Updated: 2023-04-21
Safety of RNS60 in Large Vessel Occlusion Stroke Patients Undergoing Endovascular Thrombectomy
CompletedNCT04693715
Start: 2021-07-07End: 2023-11-08Updated: 2026-01-12